1.
Verlingue L, Desevre M, Polito M, Garin G, Rodriguez C, Qing W, et al. The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST. AO [Internet]. 2024 May 28 [cited 2024 Nov. 4];63(1):411-7. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32745